Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 1252647, 8 pages
https://doi.org/10.1155/2017/1252647
Research Article

Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis

1Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China
2Division of Infectious Diseases, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China

Correspondence should be addressed to Hong Tang

Received 20 December 2016; Accepted 13 February 2017; Published 8 March 2017

Academic Editor: Shanhong Tang

Copyright © 2017 Miao Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Huang and A. S. F. Lok, “Viral factors and outcomes of chronic HBV infection,” American Journal of Gastroenterology, vol. 106, no. 1, pp. 93–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Tian, J. Li, Z.-M. Ma, C. Zhao, D.-F. Wan, and Y.-M. Wen, “Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Hildt, B. Munz, G. Saher, K. Reifenberg, and P. H. Hofschneider, “The PreS2 activator MHBst of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice,” EMBO Journal, vol. 21, no. 4, pp. 525–535, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-W. Li, F.-C. Yang, H.-Q. Lu, and J.-S. Zhang, “Hepatocellular carcinoma and hepatitis B surface protein,” World Journal of Gastroenterology, vol. 22, no. 6, pp. 1943–1952, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Giampietri, S. Petrungaro, S. Conti, A. Facchiano, A. Filippini, and E. Ziparo, “Cancer microenvironment and endoplasmic reticulum stress response,” Mediators of Inflammation, vol. 2015, Article ID 417281, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Taouji and É. Chevet, “Modulating endoplasmic reticulum stress in the treatment of cancer,” Medecine/Sciences, vol. 31, no. 6-7, pp. 667–673, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Chevet, C. Hetz, and A. Samali, “Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis,” Cancer Discovery, vol. 5, no. 6, pp. 586–597, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zanetti, J. J. Rodvold, and N. R. Mahadevan, “The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells,” Oncogene, vol. 35, no. 3, pp. 269–278, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Oliver, H. L. Roderick, D. H. Llewellyn, and S. High, “ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin,” Molecular Biology of the Cell, vol. 10, no. 8, pp. 2573–2582, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Shishkin, L. S. Eremina, L. I. Kovalev, and M. A. Kovaleva, “AGR2, ERp57/GRP58, and some other human protein disulfide isomerases,” Biochemistry (Moscow), vol. 78, no. 13, pp. 1415–1430, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Leys, S. Nomura, B. J. LaFleur et al., “Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer,” Surgery, vol. 141, no. 1, pp. 41–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Cicchillitti, A. Della Corte, M. Di Michele, M. B. Donati, D. Rotilio, and G. Scambia, “Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: the involvement of specific conformational states of β-actin,” International Journal of Oncology, vol. 37, no. 2, pp. 445–454, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. Grindel, B. Rohe, S. E. Safford, J. J. Bennett, and M. C. Farach-Carson, “Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D 3-MARRS to the nucleus,” Journal of Cellular Biochemistry, vol. 112, no. 9, pp. 2606–2615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Seliger, R. Stoehr, D. Handke et al., “Association of HLA class i antigen abnormalities with disease progression and early recurrence in prostate cancer,” Cancer Immunology, Immunotherapy, vol. 59, no. 4, pp. 529–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. De Martel, J. Ferlay, S. Franceschi et al., “Global burden of cancers attributable to infections in 2008: a review and synthetic analysis,” The Lancet Oncology, vol. 13, no. 6, pp. 607–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. T. S. Fung, J. Torres, and D. X. Liu, “The emerging roles of viroporins in ER stress response and autophagy induction during virus infection,” Viruses, vol. 7, no. 6, pp. 2834–2857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Lozano-Sepulveda, O. L. Bryan-Marrugo, C. Cordova-Fletes, M. C. Gutierrez-Ruiz, and A. M. Rivas-Estilla, “Oxidative stress modulation in hepatitis C virus infected cells,” World Journal of Hepatology, vol. 7, no. 29, pp. 2880–2889, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Safaie, M. Poongkunran, P. P. Kuang et al., “Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 22, no. 12, pp. 3404–3411, 2016. View at Google Scholar
  19. M. Wang, N. Qiu, S. Lu et al., “Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma,” Journal of Medical Virology, vol. 85, no. 2, pp. 219–227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Lee, B. K. Jang, Y. J. Lee et al., “Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis,” Clinical and Molecular Hepatology, vol. 22, no. 1, pp. 160–167, 2016. View at Publisher · View at Google Scholar
  21. E. Villa, A. Moles, I. Ferretti et al., “Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival,” Hepatology, vol. 32, no. 2, pp. 233–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Llovet, A. Burroughs, and J. Bruix, “Hepatocellular carcinoma,” Lancet, vol. 362, no. 9399, pp. 1907–1917, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-Y. Chen, F.-C. Liu, T.-S. Wu, and M.-J. Sheu, “Antrodia cinnamomea Inhibits migration in human hepatocellular carcinoma cells: the role of ERp57 and PGK-1,” American Journal of Chinese Medicine, vol. 43, no. 8, pp. 1671–1696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Chichiarelli, E. Gaucci, A. Ferraro et al., “Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line,” Archives of Biochemistry and Biophysics, vol. 494, no. 2, pp. 178–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. H. Choe, J. W. Min, H. B. Jeon et al., “ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer,” Oncotarget, vol. 6, no. 5, pp. 2654–2666, 2015. View at Publisher · View at Google Scholar · View at Scopus